Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model

International Journal of Cancer

Volumn 110, Issue 1, 2004, Pages 39-50

  Geffrotin, Claudine ^a   Crechet, Françoise ^a   Le Roy, Pascale ^b   Le Chalony, Catherine ^a   Leplat, Jean Jacques ^a   Iannuccelli, Nathalie ^b   Barbosa, Angela ^a   Renard, Christine ^a   Gruand, Joseph ^b   Milan, Denis ^b   Horak, Vratislav ^c   Tricaud, Yves ^a   Bouet, Stéphan ^a   Franck, Michel ^d   Frelat, Gérard ^a   Vincent Naulieau, Silvia ^a  

^a DIF   (France)

^b CEMAGREF   (France)

^c INSTITUTE OF ANIMAL PHYSIOLOGY AND GENETICS   (Czech Republic)

^d VETAGRO SUP   (France)

Author keywords

Animal model; Cancer genetics; Familial melanoma; MeLiM; Predisposition; Swine

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; LEUKOCYTE ANTIGEN; PROTEIN; PROTEIN MCIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME ANALYSIS; CHROMOSOME IDENTIFICATION; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; LINKAGE ANALYSIS; MALE; MELANOMA; MICROSATELLITE MARKER; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RADIATION HYBRID MAPPING; SWINE;

ANIMALS; CHROMOSOME MAPPING; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME; GENOTYPE; MALE; MELANOMA; MICROSATELLITE REPEATS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, MELANOCORTIN, TYPE 1; SWINE;

EID: 11144356953     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20053     Document Type: Article

References (83)

1. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure: recent developments in epidemiology. Arch Dermatol 1996;132:444-50.
2. Briollais L, Chompret A, Guilloud-Bataille M, Bressac de Paillerets B, Avril MF, Demenais F. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure. Int J Epidemiol 2000;29:408-15.
3. Platz A, Ringborg U, Hansson J. Hereditary cutaneous melanoma. Semin Cancer Biol 2000;10:319-26.
4. Risch N, Sherman S. Genetic analysis workshop 7: summary of the melanoma worshop. Cytogenet Cell Genet 1992;59:148-58.
5. Haluska FG, Hodi FS. Molecular genetics of familial cutaneous melanoma. J Clin Oncol 1998;16:670-82.
6. Bale SJ, Drapcoli NC, Tucker MA, Clark WH, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus syndrome to chromosome 1p. N Engl J Med 1989;320:1367-72.
7. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Diaz MO, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992;258:1148-52.
8. Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, Luxford C, Palmer JM, Donald JA, Weber JL. Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 1993;53:936-42.
9. Gruis NA, Sandkuijl LA, Weber JL. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of nevus count. Melanoma Res 1993;3:271-77.
10. Kamb A, Gruis N, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
11. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
12. Hussussian CJ, Struewing JP, Goldstein AM, Higgins P, Ally DS, Steahan MD, Clark WH, Tucker MA, Drapcoli MC. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
13. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994b;8:22-6.
14. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parrt D, Peters G, Kamb A. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995;55:2988-94.
15. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
16. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998;92:725-34.
17. Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Newton BJ, Bishop DT. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumor syndrome family. Hum Mol Genet 2001;10:55-62.
18. Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jimenez L, Mila M, Kefford RF. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF. Oncogene 2001;20:5543-7.
19. Hewitt C, Lee Wu C, Evans G, Howell A, Elles RG, Jordan R, Sloan P, Read AP, Thakker N. Germline mutation of ARF in a melanoma kindred. Hum Mol Genet 2002;11:1273-9.
20. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracpoli NC. Germline mutations in the p16/INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996;12:97-9.
21. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France: the French Familial Melanoma Study Group. Hum Mol Genet 1998;7:209-16.
22. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000;66:176-86.
23. Kennedy C, Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN. Melanocortin-1 receptor (MCIR) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117:294-300.
24. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001;69:765-73.
25. Van der Velden PA, Lodewijk A, Sandkuijl A, Bergman W, Pavel S, Van Mourik L, Frants RR, Gruis NA. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001:69:774-9.
26. Millikan LE, Boylon JL, Hook RR, Manning PJ. Melanoma in sinclair swine: a new model animal. J Inv Dermatol 1974;62:20-30.
27. Müller S, Wanke R, Distl O. Inheritance of melanocytic lesions and their association with the white colour phenotype in miniature swine. J Anim Breed Genet 2001;118:275-83.
28. Horak V, Fortyn K, Hruban V, Klaudy J. Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol 1999;45:1119-29.
29. Porter V. Pigs: a handbook to the breeds of the world. In: Helm Information. ed. Mountfield, UK 1993;151-226.
30. Das Gupta TK, Ronan SG, Beattie CW, Shlkaitis A, Amoss MS. Comparative histopathology of porcine and human cutaneous melanoma. Pediatr Dermatol 1989;6:289-99.
31. Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, Viehl P, Avril MF, Tricaud Y, Gruand J, Horak V, Frelat G, et al. Clinical and pathological characterization of cutaneous melanomas in the Melanoblastoma-bearing Libechov minipigs model. Pigment Cell Res 2004:17:24-35.
32. Tissot RG, Beattie CW, Amoss MS. Inheritance of Sinclair swine cutaneous malignant melanoma. Cancer Res 1987;47:5542-5.
33. Tissot RG, Beattie CW, Amoss MS. The swine leucocyte antigen (SLA) complex and Sinclair swine cutaneous malignant melanoma. Anim Genet 1989;20:51-7.
34. Tissot RG, Beattie CW, Amoss MS, Williams JD, Schumacher J. Common swine leukocyte antigen (SLA) haplotypes in NIH and Sinclair miniature swine have similar effects on the expression of an inherited melanoma. Anim Genet 1993;24:191-3.
35. Blangero J, Tissot RG, Beattie CW, Amoss MS. Genetic determinants of cutaneous malignant melanoma in Sinclair swine. Br J Cancer 1996;73:667-71.
36. Geffrotin C, Horak V, Crechet F, Tricaud Y, Lethias C, Vincent-Naulleau S, Vielh P. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma. Biochim Biophys Acta 2000;1524:196-202.
37. Boisgard R, Vincent-Naulleau S, Leplat JJ, Bouet S, Le Chalony C, Tricaud Y, Horak V, Geffrotin C, Frelat G, Tavitian B. A new animal model for the imaging of melanoma: correlation of FDG-PET with clinical autcome, macroscopic and histological classification in Melanoblastoma-bearing Libechov minipigs. Eur J Nucl Med Mol Imaging 2003;30:826-34.
38. Le Chalony C, Hayes H, Frelat G, Geffrotin C. Identification and mapping of swine cyclin-dependent kinase inhibitor CDKN2A and CDKN2B exon 2 sequences. Cytogenet Cell Genet 2000;88:240-3.
39. Le Chalony C, Renard C, Vincent-Naulleau S, Crechet F, Leplat JJ, Tricaud Y, Gruand J, Leroy P, Frelat G, Geffrotin C. CDKN2A/p14 ARF region polymorphism and genetic susceptibility to melanoma in the Melim swine model of familial melanoma. Int J Cancer 2003;103:631-5.
40. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomly W, Davis N, Dicks E, et al. Mutations of the BRAF gene in cancer. Nature 2002;417:949-54.
41. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, Roth JA, Albelda SM, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 2002;62:6997-7000.
42. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
43. Rogel-Gaillard C, Bourgeaux N, Billault A, Vaiman M, Chardon P. Construction of a swine BAC library: application to the characterization and mapping of porcine type C endoviral elements. Cytogenet Cell Genet 1999;85:205-11.
44. Chardon P, Rogel-Gaillard C, Peelman L, Yerle M, Velten FW, Renard C, Vaiman M. Physical organization of the pig major histocompatibility complex class II region. Immunogenetics 1999;50:344-8.
45. Yerle M, Pinton P, Robic A, Alfonso A, Palvadeau Y, Delcros C, Hawken R, Alexander L, Beattie C, Schook L, Milan D, Gellin J. Construction of a whole-genome radiation hybrid panel for high-resolution gene mapping in pigs. Cytogent Cell Genet 1998;82:182-8.
46. Hawken RJ, Murtaugh J, Flickinger GH, Yerle M, Robic A, Milan D, Gellin J, Beattie GW, Schook LB, Alexander LJ. A first-generation porcine whole-genome radiation hybrid map. Mamm Genome 1999;10:824-30.
47. Campbell EMG, Fahrenkrug SC, Vallet JL, Smith TPL, Rohrer GA. An updated linkage and comparative map of porcine chromosome 18. Anim Genet 2001:32:375-9.
48. Bidanel JP, Milan D, Iannuccelli N, Amigues Y, Boscher MY, Bourgeois F, Caritez JC, Gruand J, Le Roy P, Lagant H, Quintanilla R, Renard C, et al. Detection of quantitative trait loci for growth and fatness in pigs. Genet Sel Evol 2001;33:289-309.
49. Elsen JM, Manjin B, Goffinet B, Boichard D, Le Roy P. Alternative models for QTL detection in livestock: 1. general introduction. Genet Sel Evol 1999;31:213-24.
50. Spielman RS, Ewens W. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-9.
51. Spielman RS, McGinnis RE, Ewens W. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
52. Chardon P, Rogel-Gaillard C, Cattolico L, Duprat S, Vaiman M, Renard C. Sequence of the swine major histocompatibility complex region containing all non-classical class 1 genes. Tissue Antigens 2001;57:55-65.
53. Renard C, Vaiman M, Chiannilkulchai N, Cattolico L, Robert C, Chardon P. Sequence of the pig major histocompatibility region containing the classical class I genes. Immunogenetics 2001;53:490-500.
54. Gianola D. Theory and analysis of threshold characters. J Anim Sci 1982;54:1079-96.
55. Grange F, Chompret A, Guilloud-Bataille M, Guillaume JC, Marguris A, Prade M, Demenais F, Avril MF. Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 1995;131:1154-9.
56. Goureau A, Yerle M, Schmitz A, Riquet J, Milan D, Pinton, P, Frelat G, Gellin J. Human and porcine correspondence of chromosome segments using bidirectional chromosome painting. Genomics 1996;36:252-62.
57. Hordinsky MK, Ruth G, King R. Inheritance of melanocytic tumors in Duroc swine. J Hered 1985;76:385-6.
58. Levkut M, Kolodzieyski L, Ledecky V, Daxnerova K. Familial melanoma in the progeny of a Duroc and Slovak white crossbred sow. J Comp Path 1995;113:233-9.
59. Van der Velden PA, Sandkuijl LA, Bergman W, Hille ETM, Frants RR, Gruis NA. A locus linked to p16 modifies melanoma risk in Dutch Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome families. Genome Res 1999;9:575-80.
60. Parris CN, Harris JD, Griffin DK, Cuthbert AP, Silver AJR, Newbold RF. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res 1999;59:516-20.
61. Pollock PM, Welch J, Hayward NK. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res 2001;61:1154-61.
62. Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997;6:1891-7.
63. Shaffer JV, Bolognia JL. The melanocortin-1 receptor. Red Hair and Beyond. Arch Dermatol 2001;137:1477-85.
64. Leonard JH, Marks LH, Chen W, Cook AL, Boyle GM, Smit DJ, Brown DL, Stow JL, Parsons PG, Sturm RA. Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies. Pigment Cell Res 2003;16:198-207.
65. Kijas JMH, Wales R, Törnsten A, Chardon P, Moller M, Andersson L. Melanocortin receptor 1 (MC1R) mutations and coat color in pigs. Genetics 1998;150:1177-85.
66. Kijas JMH, Moller M, Plastow G, Andersson L. A frameshift mutation in MC1R and a high frequency of somatic reversions cause black spotting in pigs. Genetics 2001;158:779-85.
67. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, Cone RD. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993;72:827-34.
68. Demenais F, Cesarini JP, Daveau M, Cavelier B, Gony J, Feingold N, Hors J. A linkage study between HLA and cutaneous malignant melanoma or precursor lesions or both. J Med Genet 1984;21:429-35.
69. Walker GJ, Nancarrow DJ, Walters MK, Palmere JM, Hayward NK. Linkage analysis in familial melanoma kindreds to marker on chromosome 6p. Int J Cancer 1994;59:771-7.
70. Bale SJ, Greene MH, Murray C, Goldin LR, Johnson AH, Mann D. Hereditary malignant melanoma is not linked to the HLA complex on chromosome 6. Int J Cancer 1985;36:439-43.
71. Renard C, Kristensen B, Gautschi C, Hruban V, Fredholm M, Vaiman M. Joint report of the first international comparison test on swine lymphocyte alloantigens (SLA). Anim Genet 1988;19:63-72.
72. Matsumoto KI, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, Nakatsuji N, Ariga H. Tumor invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 2001;6:1101-11.
73. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. BioEssay 2003;5:577-88.
74. Jeon JT, Carlborg O, Tornsten A, Griuffra E, Amarger V, Chardon P, Andersson-Eklund L, Andersson K, Hansson I, Lundstron K, Andersson L. A paternally expressed QTL affecting skeletal and cardiac muscle mass in pig maps to the IGF2 locus. Nat Genet 1999;21:157-8.
75. Hirooka H, de Koning DJ, van Arendonk JAM, Harlizius B, de Groot PN, Bovenhuis H. Genome scan reveals new coat color loci in exotic pig cross. J Hered 2002;93:1-8.
76. Johansson-Moller M, Chandhary R, Hellman E, Hoyheim B, Chowdhary B, Andersson L. Pigs with the dominant white coat color phenotype carry a duplication of the KIT gene encoding the mast/stem cell growth factor receptor. Mamm Genome 1996;7:822-30.
77. Distl O, Müller S, Moller M, Wanke R, Hermanns W, Andersson L. Inheritance of melanocytic lesions and their association with the white colour phenotype in miniature swine. Proc World Congress Genet Appl Livestock Prod 1998;26:445-8.
78. Natali PG, Nicotra MR, Winkler AB, Cavaliere R, Bigotti A, Ullrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 1992;52:197-201.
79. Ohashi A, Funasaka Y, Ueda M, Ichihashi M. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res 1996;6:25-30.
80. Montone KT, van Belle P, Elenitsas R, Elder DE. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol 1997;10:939-44.
81. Shabhazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, Hutchinson E, Osborne KE, Lear J, Smith AG, Hutchinson IV. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002;359:397-401.
82. V599E as a melanoma susceptibility mutation. Int J Cancer 2003;6:78-80.
83. Laud K, Kannengiesser C, Avril MF, Chompret A, Stoppa-Lyonnet D, Desjardins L, Eychene A, Demenais F, Lenoir GM, Bressac-de Paillerets, French Hereditary Melanoma Study Group. BRAF as a melanoma susceptibilty candidate gene? Cancer Res 2003;63:3061-5.